A boy with cutaneous necrosis occurring during treatment with levamisole

Clinical and Experimental Dermatology

Volumn 27, Issue 1, 2002, Pages 32-33

  Powell, J ^a,b   Grech, H ^a   Holder, J ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^b Churchill Hopital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR 5 LEIDEN; CYCLOPHOSPHAMIDE; HEPARIN; LEVAMISOLE; LUPUS ANTICOAGULANT; PREDNISOLONE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; DISEASE COURSE; GENETIC PREDISPOSITION; HETEROZYGOSITY; HISTOLOGY; HUMAN; LABORATORY TEST; LONG TERM CARE; MALE; PRIORITY JOURNAL; PURPURA; SCHOOL CHILD; SKIN NECROSIS; SYMPTOMATOLOGY; THROMBOGENESIS;

ADJUVANTS, IMMUNOLOGIC; CHILD; DRUG ERUPTIONS; FACTOR V; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEG ULCER; LEVAMISOLE; MALE; NECROSIS; SKIN;

EID: 0036226453     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0307-6938.2001.00944.x     Document Type: Article

References (4)

1. Levamisole for corticosteroid-dependant nephrotic syndrome in childhood
2. Purpura of the ears: A distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children
3. Widespread cutaneous necrosis associated with the lupus anticoagulant
4. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis